Bruce Jackson

Work

Analyst Bruce Jackson works at BENCHMARK and is focused on the Healthcare sector with 130 price targets and ratings documented since 2015 spanning on 14 stocks. Analyst's average stock valuation to be materialised ratio is 56.5% with an average time for price targets to be met of 226.46 days.

Most recent stock forecast was given on NEO, NeoGenomics, Inc at 26-Aug-2022.

Bruce Jackson best performing recommendations are on CEMI (CHEMBIO DIAGNOSTICS, INC).
The best stock recommendation documented was for SEEL at 3/9/2021. The price target of $6 was fulfilled within 45 days with a profit of $2.98 (98.68%) receiving and performance score of 21.93.

Average potential price target upside

CEMI FLXN HBIO NEO NVTA OCX SEEL SKIN STAA EXAS MDXG BFRA CLNN UNCY
CEMI FLXN HBIO NEO NVTA OCX SEEL SKIN STAA EXAS MDXG BFRA CLNN UNCY